Marc Samuels Comments on GLP-1s with Scrip

Health Policy & Access Strategy Pharmaceuticals and Biotech

February 21, 2024

On February 14, 2024, ADVI Health’s CEO and president, Marc Samuels, shared insight on GLP-1s with Scrip’s analysis: Scrip Asks….What Does 2024 Hold For Biopharma?

In his interview, Marc shared insights into the future of GLP-1s and what factors might enhance market opportunities in the coming years.

Read more on Marc’s insights.

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.

Start now.